Big Losses Loom for Big Pharma
Dan Whalen is a JD candidate at Osgoode Hall Law School. The New York Times reported that many of the major players in the global
March 25, 2011
1 Comment
Tag: Pharmaceutical Drugs
Efficacy of TRIPS public health amendment raises concern at the WTO
Nirav Bhatt is an LLM candidate at Osgoode Hall Law School. WTO members on 2 March 2010, debated the question of whether a 2003 decision
March 18, 2010
No Comments
Pooling patents for HIV drugs: A paradigm shift
Nirav Bhatt is an LLM candidate at Osgoode Hall Law School. According to a report, AIDS, which is caused due to Human immunodeficiency virus (HIV)
October 16, 2009
No Comments
Federal Court Ruling Upholds Data Protection Period for Research-Based, Innovative Drug Companies
The period of data protection allocated to research-based, innovative drug companies is a hotly debated topic in the pharmaceutical industry and beyond. This period of protection
August 7, 2009
2 Comments
The Efficacy Standard – India’s New Patentability Criteria
Nigel D’Souza is a JD Candidate at Osgoode Hall Law School. I have been researching at Human Rights Law Network for over a month now
August 3, 2009
1 Comment
United States Doctrine of Inequitable Conduct Under Scrutiny Again
The controversial doctrine of inequitable conduct has once again garnered much attention in the patent law community due to the recent denial of certiorari by the US
May 5, 2009
No Comments